INHIBRX BIOSCIENCES, INC. (INBX) Operating cash flow 2023–2025
INHIBRX BIOSCIENCES, INC. (INBX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$129.8MFY2025 · since FY2023: -$193.3M → -$129.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$129.8M | +33.2% |
| FY2024 | -$194.4M | -0.6% |
| FY2023 | -$193.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More INBX financial trends
INBX RevenueINBX Net incomeINBX Net marginINBX Gross profitINBX Gross marginINBX Operating incomeINBX Operating marginINBX Free cash flowINBX Capital expendituresINBX Return on equityINBX Stock buybacksINBX Dividends paidINBX Total assetsINBX Total liabilitiesINBX Shareholders’ equityINBX overview →